On Invalid Date, Medpace Holdings (NASDAQ: MEDP) reported Q4 2022 earnings per share (EPS) of $2.18, up 56.83% year over year. Total Medpace Holdings earnings for the quarter were $68.67 million. In the same quarter last year, Medpace Holdings's earnings per share (EPS) was $1.39.
As of Q1 2023, Medpace Holdings's earnings has grown 49.6% year over year. This is 44.27 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 5.34%. Medpace Holdings's earnings in the past year totalled $245.37 million.
What is MEDP's earnings date?
Medpace Holdings's earnings date is Invalid Date. Add MEDP to your watchlist to be reminded of MEDP's next earnings announcement.
What was MEDP's revenue last quarter?
On Invalid Date, Medpace Holdings (NASDAQ: MEDP) reported Q4 2022 revenue of $394.10 million up 27.72% year over year. In the same quarter last year, Medpace Holdings's revenue was $308.55 million.
What was MEDP's revenue growth in the past year?
As of Q1 2023, Medpace Holdings's revenue has grown 27.8% year over year. This is 17.17 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 10.63%. Medpace Holdings's revenue in the past year totalled $1.46 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.